Annual EBIT:
-$86.62M-$15.25M(-21.36%)Summary
- As of today, TSHA annual earnings before interest & taxes is -$86.62 million, with the most recent change of -$15.25 million (-21.36%) on December 31, 2024.
- During the last 3 years, TSHA annual EBIT has risen by +$86.65 million (+50.01%).
- TSHA annual EBIT is now -7668.70% below its all-time high of -$1.11 million, reached on December 31, 2019.
Performance
TSHA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$34.02M-$7.27M(-27.18%)Summary
- As of today, TSHA quarterly earnings before interest & taxes is -$34.02 million, with the most recent change of -$7.27 million (-27.18%) on September 30, 2025.
- Over the past year, TSHA quarterly EBIT has dropped by -$12.96 million (-61.56%).
- TSHA quarterly EBIT is now -2951.48% below its all-time high of -$1.11 million, reached on December 1, 2019.
Performance
TSHA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$102.13M-$12.96M(-14.54%)Summary
- As of today, TSHA TTM earnings before interest & taxes is -$102.13 million, with the most recent change of -$12.96 million (-14.54%) on September 30, 2025.
- Over the past year, TSHA TTM EBIT has dropped by -$19.64 million (-23.81%).
- TSHA TTM EBIT is now -9059.64% below its all-time high of -$1.11 million, reached on December 1, 2019.
Performance
TSHA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TSHA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -21.4% | -61.6% | -23.8% |
| 3Y3 Years | +50.0% | -33.6% | +34.4% |
| 5Y5 Years | -7668.7% | -126.2% | -369.8% |
TSHA EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -21.4% | +50.0% | -117.6% | at low | -43.1% | +34.4% |
| 5Y | 5-Year | -7668.7% | +50.0% | -126.2% | +32.9% | -369.8% | +45.7% |
| All-Time | All-Time | -7668.7% | +50.0% | -2951.5% | +32.9% | -9059.6% | +45.7% |
TSHA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$34.02M(-27.2%) | -$102.13M(-14.5%) |
| Jun 2025 | - | -$26.75M(-24.9%) | -$89.17M(-6.5%) |
| Mar 2025 | - | -$21.42M(-7.5%) | -$83.71M(+3.4%) |
| Dec 2024 | -$86.62M(-21.4%) | -$19.93M(+5.4%) | -$86.62M(-5.0%) |
| Sep 2024 | - | -$21.06M(+1.1%) | -$82.49M(-7.0%) |
| Jun 2024 | - | -$21.30M(+12.5%) | -$77.06M(+2.6%) |
| Mar 2024 | - | -$24.33M(-54.0%) | -$79.14M(-10.9%) |
| Dec 2023 | -$71.37M(+43.4%) | -$15.80M(-1.0%) | -$71.37M(+3.9%) |
| Sep 2023 | - | -$15.63M(+33.1%) | -$74.28M(+11.7%) |
| Jun 2023 | - | -$23.38M(-41.2%) | -$84.10M(+10.6%) |
| Mar 2023 | - | -$16.56M(+11.4%) | -$94.09M(+24.5%) |
| Dec 2022 | -$126.03M | -$18.70M(+26.5%) | -$124.58M(+19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$25.46M(+23.7%) | -$155.60M(+13.9%) |
| Jun 2022 | - | -$33.37M(+29.1%) | -$180.83M(+3.9%) |
| Mar 2022 | - | -$47.05M(+5.4%) | -$188.23M(-8.6%) |
| Dec 2021 | -$173.27M(-302.9%) | -$49.72M(+1.9%) | -$173.27M(-22.1%) |
| Sep 2021 | - | -$50.68M(-24.3%) | -$141.91M(-33.5%) |
| Jun 2021 | - | -$40.77M(-27.1%) | -$106.27M(-62.2%) |
| Mar 2021 | - | -$32.09M(-74.7%) | -$65.50M(-68.0%) |
| Dec 2020 | -$43.00M(-3756.7%) | - | - |
| Dec 2020 | - | -$18.37M(-22.1%) | -$38.99M(-79.4%) |
| Sep 2020 | - | -$15.04M(-169.4%) | -$21.74M(-224.5%) |
| Mar 2020 | - | -$5.58M(-400.8%) | -$6.70M(-500.8%) |
| Dec 2019 | -$1.11M | - | - |
| Dec 2019 | - | -$1.11M | -$1.11M |
FAQ
- What is Taysha Gene Therapies, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual EBIT year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly EBIT year-on-year change?
- What is Taysha Gene Therapies, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. TTM EBIT year-on-year change?
What is Taysha Gene Therapies, Inc. annual earnings before interest & taxes?
The current annual EBIT of TSHA is -$86.62M
What is the all-time high annual EBIT for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual earnings before interest & taxes is -$1.11M
What is Taysha Gene Therapies, Inc. annual EBIT year-on-year change?
Over the past year, TSHA annual earnings before interest & taxes has changed by -$15.25M (-21.36%)
What is Taysha Gene Therapies, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of TSHA is -$34.02M
What is the all-time high quarterly EBIT for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly earnings before interest & taxes is -$1.11M
What is Taysha Gene Therapies, Inc. quarterly EBIT year-on-year change?
Over the past year, TSHA quarterly earnings before interest & taxes has changed by -$12.96M (-61.56%)
What is Taysha Gene Therapies, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of TSHA is -$102.13M
What is the all-time high TTM EBIT for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high TTM earnings before interest & taxes is -$1.11M
What is Taysha Gene Therapies, Inc. TTM EBIT year-on-year change?
Over the past year, TSHA TTM earnings before interest & taxes has changed by -$19.64M (-23.81%)